Checkpoint Therapeutics, Inc. (CKPT) Social Stream
CHECKPOINT THERAPEUTICS INC (CKPT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CKPT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 4 | $20 | $16 | $17.75 | $2.44 | 627.46% |
| 2022-01-25 | 4 | $26 | $16 | $20 | $2.44 | 719.67% |
| 2022-01-26 | 4 | $26 | $18 | $21 | $2.44 | 760.66% |
| 2022-05-17 | 4 | $26 | $18 | $22.5 | $2.44 | 822.13% |
| 2022-07-14 | 3 | $26 | $7 | $19.75 | $2.44 | 709.43% |
| 2022-08-15 | 3 | $26 | $7 | $18.5 | $2.44 | 658.2% |
| 2022-12-02 | 4 | $26 | $7 | $18.5 | $2.44 | 658.2% |
| 2022-12-19 | 4 | $260 | $150 | $205 | $2.44 | 8301.64% |
| 2022-12-23 | 4 | $260 | $76 | $159 | $2.44 | 6416.39% |
| 2023-01-05 | 3 | $150 | $76 | $118 | $2.44 | 4736.07% |
| 2023-03-02 | 4 | $150 | $76 | $118 | $2.44 | 4736.07% |
| 2023-03-03 | 4 | $150 | $54 | $94 | $2.44 | 3752.46% |
| 2023-04-03 | 4 | $150 | $54 | $87.25 | $2.44 | 3475.82% |
| 2023-04-04 | 5 | $150 | $22 | $74.2 | $2.44 | 2940.98% |
| 2023-04-28 | 5 | $150 | $22 | $65.8 | $2.44 | 2596.72% |
| 2023-05-17 | 5 | $150 | $19 | $58 | $2.44 | 2277.05% |
| 2023-07-11 | 4 | $150 | $16 | $56.8 | $2.44 | 2227.87% |
| 2023-08-04 | 5 | $150 | $16 | $56.8 | $2.44 | 2227.87% |
| 2023-08-16 | 5 | $150 | $14 | $52.2 | $2.44 | 2039.34% |
| 2023-10-18 | 5 | $47 | $8 | $23.4 | $2.44 | 859.02% |
| 2023-12-19 | 4 | $47 | $8 | $24.25 | $2.44 | 893.85% |
| 2023-12-20 | 4 | $34 | $4 | $18.25 | $2.44 | 647.95% |
The Trend in the Analyst Price Target
Over the past 12 months, CKPT's average price target has gone down $186.75.
Over the past 50 weeks, CKPT's average upside potential has been 1,914.84%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-05 | 4 | 150 | 76 | 118.00 | 5.83 | 1924.01% |
| 2023-03-02 | 4 | 150 | 76 | 118.00 | 5.06 | 2232.02% |
| 2023-04-04 | 5 | 150 | 22 | 74.20 | 2.31 | 3112.12% |
| 2023-07-11 | 5 | 150 | 16 | 56.80 | 2.62 | 2067.94% |
| 2023-12-20 | 4 | 34 | 4 | 18.25 | 1.76 | 936.93% |
CKPT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
CKPT's average broker recommendation rating improved by 0 over the prior 31 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how CHECKPOINT THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 2643% of that group.
- To contextualize these metrics, consider that out of all US stocks, CHECKPOINT THERAPEUTICS INC's variance in analysts' estimates is lower than -2155.96% of them.
- In the context of Healthcare stocks, CHECKPOINT THERAPEUTICS INC's number of analysts covering the stock is higher than 488.25% of them.
- CHECKPOINT THERAPEUTICS INC's average analyst price target is higher than 2116.97% of stocks in the small market cap category.
Stocks similar to CHECKPOINT THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ABEO, SYRS, and CLSD.
View All Top Stocks by Price Target
Is CKPT a Buy, Hold or Sell? See the POWR Ratings now!